Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Total Research and Development (R&D) expenses by Year
Total Research and Development (R&D) expenses ($M) ($M)
Vertex Pharmaceuticals Total Research and Development (R&D) expenses: $3,910M in FY2025, up 7.7% from a year earlier. That is the highest of the 18 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Operations & MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Research and Development (R&D) expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,910 | +7.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 3,630 | +14.8% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 3,163 | +24.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 2,540 | +31.1% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 1,938 | +17.8% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 1,645 | -6.2% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 1,755 | +23.9% | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 1,417 | +6.9% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 1,325 | +26.4% | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,048 | +5.2% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 996 | +16.4% | Form 10-K (filed 2018-02-15) ↗ |
| FY2014 | Dec 31, 2014 | 856 | -3.0% | Form 10-K (filed 2015-02-13) ↗ |
| FY2013 | Dec 31, 2013 | 882 | +15.2% | Form 10-K (filed 2015-02-13) ↗ |
| FY2012 | Dec 31, 2012 | 766 | +8.2% | Form 10-K (filed 2015-02-13) ↗ |
| FY2011 | Dec 31, 2011 | 708 | +11.0% | Form 10-K (filed 2012-02-22) ↗ |
| FY2010 | Dec 31, 2010 | 637 | +15.8% | Form 10-K (filed 2011-02-17) ↗ |
| FY2009 | Dec 31, 2009 | 550 | +6.5% | Form 10-K (filed 2011-02-17) ↗ |
| FY2008 | Dec 31, 2008 | 517 | – | Form 10-K (filed 2011-02-17) ↗ |
Breakdown
What makes up total Research and Development (R&D) expenses
Cite this data
StockData. (2026). Vertex Pharmaceuticals Total Research and Development (R&D) expenses ($M), annual FY2008–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-total
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.